Form 8-K - Current report:
SEC Accession No. 0001104659-24-098326
Filing Date
2024-09-10
Accepted
2024-09-10 06:02:13
Documents
61
Period of Report
2024-09-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2423596d1_8k.htm   iXBRL 8-K 24599
2 EXHIBIT 99.1 tm2423596d1_ex99-1.htm EX-99.1 72264
6 GRAPHIC tm2423596d1_ex99-1img001.jpg GRAPHIC 149740
7 GRAPHIC tm2423596d1_ex99-1img002.jpg GRAPHIC 316031
8 GRAPHIC tm2423596d1_ex99-1img003.jpg GRAPHIC 133633
9 GRAPHIC tm2423596d1_ex99-1img004.jpg GRAPHIC 140493
10 GRAPHIC tm2423596d1_ex99-1img005.jpg GRAPHIC 146724
11 GRAPHIC tm2423596d1_ex99-1img006.jpg GRAPHIC 57642
12 GRAPHIC tm2423596d1_ex99-1img007.jpg GRAPHIC 94620
13 GRAPHIC tm2423596d1_ex99-1img008.jpg GRAPHIC 132040
14 GRAPHIC tm2423596d1_ex99-1img009.jpg GRAPHIC 164284
15 GRAPHIC tm2423596d1_ex99-1img010.jpg GRAPHIC 154556
16 GRAPHIC tm2423596d1_ex99-1img011.jpg GRAPHIC 118089
17 GRAPHIC tm2423596d1_ex99-1img012.jpg GRAPHIC 99288
18 GRAPHIC tm2423596d1_ex99-1img013.jpg GRAPHIC 108888
19 GRAPHIC tm2423596d1_ex99-1img014.jpg GRAPHIC 141900
20 GRAPHIC tm2423596d1_ex99-1img015.jpg GRAPHIC 183104
21 GRAPHIC tm2423596d1_ex99-1img016.jpg GRAPHIC 68317
22 GRAPHIC tm2423596d1_ex99-1img017.jpg GRAPHIC 117009
23 GRAPHIC tm2423596d1_ex99-1img018.jpg GRAPHIC 138905
24 GRAPHIC tm2423596d1_ex99-1img019.jpg GRAPHIC 138177
25 GRAPHIC tm2423596d1_ex99-1img020.jpg GRAPHIC 105546
26 GRAPHIC tm2423596d1_ex99-1img021.jpg GRAPHIC 110933
27 GRAPHIC tm2423596d1_ex99-1img022.jpg GRAPHIC 124336
28 GRAPHIC tm2423596d1_ex99-1img023.jpg GRAPHIC 41939
29 GRAPHIC tm2423596d1_ex99-1img024.jpg GRAPHIC 106215
30 GRAPHIC tm2423596d1_ex99-1img025.jpg GRAPHIC 102103
31 GRAPHIC tm2423596d1_ex99-1img026.jpg GRAPHIC 136233
32 GRAPHIC tm2423596d1_ex99-1img027.jpg GRAPHIC 120936
33 GRAPHIC tm2423596d1_ex99-1img028.jpg GRAPHIC 111415
34 GRAPHIC tm2423596d1_ex99-1img029.jpg GRAPHIC 41522
35 GRAPHIC tm2423596d1_ex99-1img030.jpg GRAPHIC 99176
36 GRAPHIC tm2423596d1_ex99-1img031.jpg GRAPHIC 105881
37 GRAPHIC tm2423596d1_ex99-1img032.jpg GRAPHIC 147127
38 GRAPHIC tm2423596d1_ex99-1img033.jpg GRAPHIC 54014
39 GRAPHIC tm2423596d1_ex99-1img034.jpg GRAPHIC 139498
40 GRAPHIC tm2423596d1_ex99-1img035.jpg GRAPHIC 139131
41 GRAPHIC tm2423596d1_ex99-1img036.jpg GRAPHIC 118708
42 GRAPHIC tm2423596d1_ex99-1img037.jpg GRAPHIC 33083
43 GRAPHIC tm2423596d1_ex99-1img038.jpg GRAPHIC 104236
44 GRAPHIC tm2423596d1_ex99-1img039.jpg GRAPHIC 111490
45 GRAPHIC tm2423596d1_ex99-1img040.jpg GRAPHIC 145689
46 GRAPHIC tm2423596d1_ex99-1img041.jpg GRAPHIC 127996
47 GRAPHIC tm2423596d1_ex99-1img042.jpg GRAPHIC 38315
48 GRAPHIC tm2423596d1_ex99-1img043.jpg GRAPHIC 209125
49 GRAPHIC tm2423596d1_ex99-1img044.jpg GRAPHIC 93095
50 GRAPHIC tm2423596d1_ex99-1img045.jpg GRAPHIC 135363
51 GRAPHIC tm2423596d1_ex99-1img046.jpg GRAPHIC 93408
52 GRAPHIC tm2423596d1_ex99-1img047.jpg GRAPHIC 85334
  Complete submission text file 0001104659-24-098326.txt   7976947

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tbph-20240910.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20240910_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20240910_pre.xml EX-101.PRE 22363
63 EXTRACTED XBRL INSTANCE DOCUMENT tm2423596d1_8k_htm.xml XML 3705
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 241288674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)